Commonwealth Bank of Australia’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-3,427
| Closed | -$626K | – | 926 |
|
2019
Q2 | $626K | Buy |
3,427
+721
| +27% | +$132K | 0.01% | 659 |
|
2019
Q1 | $496K | Buy |
2,706
+183
| +7% | +$33.5K | ﹤0.01% | 641 |
|
2018
Q4 | $415K | Buy |
2,523
+163
| +7% | +$26.8K | ﹤0.01% | 641 |
|
2018
Q3 | $453K | Buy |
2,360
+28
| +1% | +$5.38K | ﹤0.01% | 688 |
|
2018
Q2 | $395K | Buy |
2,332
+132
| +6% | +$22.4K | ﹤0.01% | 600 |
|
2018
Q1 | $357K | Sell |
2,200
-459
| -17% | -$74.5K | ﹤0.01% | 565 |
|
2017
Q4 | $395K | Sell |
2,659
-155
| -6% | -$23K | ﹤0.01% | 562 |
|
2017
Q3 | $425K | Sell |
2,814
-718
| -20% | -$108K | ﹤0.01% | 573 |
|
2017
Q2 | $453K | Buy |
3,532
+190
| +6% | +$24.4K | ﹤0.01% | 591 |
|
2017
Q1 | $365K | Buy |
3,342
+2,381
| +248% | +$260K | ﹤0.01% | 594 |
|
2016
Q4 | $71K | Buy |
961
+145
| +18% | +$10.7K | ﹤0.01% | 707 |
|
2016
Q3 | $71K | Hold |
816
| – | – | ﹤0.01% | 701 |
|
2016
Q2 | $71K | Buy |
816
+90
| +12% | +$7.83K | ﹤0.01% | 680 |
|
2016
Q1 | $58K | Buy |
726
+190
| +35% | +$15.2K | ﹤0.01% | 735 |
|
2015
Q4 | $67K | Buy |
536
+190
| +55% | +$23.8K | ﹤0.01% | 714 |
|
2015
Q3 | $36K | Buy |
346
+11
| +3% | +$1.15K | ﹤0.01% | 785 |
|
2015
Q2 | $41K | Buy |
335
+35
| +12% | +$4.28K | ﹤0.01% | 729 |
|
2015
Q1 | $35K | Hold |
300
| – | – | ﹤0.01% | 735 |
|
2014
Q4 | $36K | Sell |
300
-6,000
| -95% | -$720K | ﹤0.01% | 713 |
|
2014
Q3 | $708K | Sell |
6,300
-400
| -6% | -$45K | 0.01% | 539 |
|
2014
Q2 | $634K | Sell |
6,700
-116,732
| -95% | -$11M | 0.01% | 546 |
|
2014
Q1 | $8.73M | Sell |
123,432
-5,520
| -4% | -$390K | 0.06% | 320 |
|
2013
Q4 | $9.58M | Buy |
128,952
+40,078
| +45% | +$2.98M | 0.07% | 285 |
|
2013
Q3 | $6.74M | Sell |
88,874
-21,210
| -19% | -$1.61M | 0.05% | 332 |
|
2013
Q2 | $8.81M | Buy |
+110,084
| New | +$8.81M | 0.07% | 263 |
|